Media Advisory - Neo Performance Materials Inc. Third Quarter 2024 Earnings Release & Conference Call
Werte in diesem Artikel
TORONTO, Oct. 28, 2024 /CNW/ - Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) will report its third-quarter results for the period ended September 30, 2024, before the Toronto market opens on Thursday, November 14, 2024.
Teleconference Call
Management will host a teleconference call on Thursday, November 14, 2024 at 10:00 a.m. (Eastern Time) to discuss the third quarter 2024 results.
Interested parties may access the teleconference or webcast. For teleconference, visit https://emportal.ink/47VV4nB or call 1-437-900-0527 (local) or 1-888-510-2154 (toll-free long distance). For the webcast, visit https://app.webinar.net/v32pRWbDxgQ.
A recording of the teleconference may be accessed by calling (289) 819-1450 (local) or (888) 660-6345 (toll-free long distance) and entering passcode 40961# until December 14, 2024.
About Neo Performance Materials
Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability. Neo's advanced industrial materials – magnetic powders and magnets, specialty chemicals, metals, and alloys – are critical to the performance of many everyday products and emerging technologies. Neo's products help to deliver the technologies of tomorrow to consumers today. Neo's business is organized into three segments: Magnequench, Chemicals & Oxides, and Rare Metals. Neo is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, United States; Singapore; and Beijing, China. Neo has a global platform that includes ten manufacturing facilities located in Canada, China, Estonia, Germany, Thailand, the United Kingdom, and the United States, as well as one dedicated research and development centre in Singapore.
SOURCE Neo Performance Materials, Inc.
Ausgewählte Hebelprodukte auf Neogenomics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Neogenomics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Neogenomics IncShs
Analysen zu Neogenomics IncShs
Datum | Rating | Analyst | |
---|---|---|---|
01.05.2019 | Neogenomics Buy | Needham & Company, LLC | |
29.03.2019 | Neogenomics Buy | Needham & Company, LLC | |
03.01.2019 | Neogenomics Buy | Needham & Company, LLC | |
24.10.2018 | Neogenomics Strong Buy | First Analysis Securities | |
02.05.2018 | Neogenomics Equal-Weight | First Analysis Securities |
Datum | Rating | Analyst | |
---|---|---|---|
01.05.2019 | Neogenomics Buy | Needham & Company, LLC | |
29.03.2019 | Neogenomics Buy | Needham & Company, LLC | |
03.01.2019 | Neogenomics Buy | Needham & Company, LLC | |
24.10.2018 | Neogenomics Strong Buy | First Analysis Securities | |
24.08.2017 | Neogenomics Buy | Gabelli & Co |
Datum | Rating | Analyst | |
---|---|---|---|
02.05.2018 | Neogenomics Equal-Weight | First Analysis Securities | |
11.09.2017 | Neogenomics Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
21.08.2007 | Neogenomics konsequent zurückziehen | Global Biotech Investing |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogenomics IncShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen